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The North Jutland County Diabetic Retinopathy Study (NCDRS)
Population Characteristics
LL Knudsen 1A, HH Lervang 1B, S Lundbye-Christensen 2 and A Gorst-Rasmussen 2
AOphthalmology, BMedical Endocrinology , 1Aalborg Sygehus Syd; Aarhus University Hospital, Aalborg, Denmark; 
2Department of Mathematical Sciences, Aalborg University, Aalborg, Denmark
Purpose
Several population based studies have reported blood 
glucose and blood pressure to be risk factors for 
development of proliferative retinopathy and diabetic 
maculopathy. These studies were initiated decades ago 
and may therefore reflect treatment and composition of 
a previous era. This study included the present diabetic 
population in the County of North Jutland, Denmark.
Methods
This cross-section study included 656 type 1 and 328 type 
2 diabetic subjects undergoing retinopathy screening in 
the county of North Jutland in the period 1st April 2000 
to 30th April 2004. Type 1 diabetic subjects were nearly 
entirely included from larger Aalborg (an urban area in 
the County of North Jutland) representing 70-75 % of all 
type 1 diabetic subjects. Type 2 diabetic subjects were 
enrolled from the entire County and comprised less than 
5 % of all type 2 diabetic subjects.
Crude prevalence rates for several retinal manifestations 
are presented together with their association to an 
internationally approved retinopathy scale [1].
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Retinopathy grading 
Level Definition
0 No retinal abnormality
1 Microaneurysms only
2 More than just microaneurysms but less than level 3
3
Any of the following: 20 or more intraretinal haemorrhages in each of the 
4quadrants; definite venous beading in 2 or more quadrants; prominent IRMA in 
one or more quadrant and no sign of proliferative retinopathy
4a Newly diagnosed neovascularization without signs or history of laser treatment
4b Visibly previous laser treatment or history of such treatment
Definition of macular oedema
Clinically significant macular oedema
The presence or absence of clinically significant macular oedema was registered following a 
clinical examination and using the ETDRS criteria.
Results
Table 1
Populat1on characteristic parameters
Type 1 Type 2 diabetes
N 656 328
Age at entry (years) 37.3 58.1
Duration of diabetes (years) 17.6 8.0
Age at diagnosis (years) 19.0 48.0
Female participants (%) 51.7 % 45.1 %
Height (cm) 172.0 171.0
Weig                 ht (kg) 72.0 88.0
BMI (kg/m2) 24.1 29.7
HbA1c (%) 8.3 8.1
Diastolic blood pressure 80.0 80.0
Systolic blood pressure (mmHg) 130.0 140.0
Neuropathy (%) 9.1 18.0
BP reducing medication (%) 26.2 57.6
Oral antidiabetics (%) 0.0 36.3
Insulin (%) 100 64.9
Lipid lowering medication (%) 6.7 27.1
Table 2
Visual acuity at various retinopathy levels
Type 1 diabetes Type 2 diabetes
Visual acuity No Visual acuity No
All 0.90 656 0.85 328
0 1.00 303 0.90 201
1 1.00 136 0.8. 41
2 0.90 161 0.80 71
3 0.90 19 0.80 12
4a 0.60 5 0.50 1
4b 0.80 32 0.65 2
Table 3
Point prevalence of proliferative retinopathy and 
clinically significant macular oedema
Type 1 diabetes Type 2 diabetes
Proliferative retinopathy 0.8 % 0.3 %
Clinically significant macular 7.9 % 12.8 %
Table 4
The prevalence of rare retinal lesions.
Rare retinal lesions Prevalence
White blood vessels 9/984:   0.9 %
Fibrous tissue 12/984: 1.2 %
Venous beading 25/984: 2.5 %
Venous loop 8/984:   0.8 %
Double contoured vessels 7/984:   0.7 %
IRMA 23/984: 2.3 %
Preretinal haemorrhages 1/984:   0.1 %
Vitreous haemorrhages 0/984:   0.0 %
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Fig 1
A comparison of previous (WESDR) [2] and 
present (NCDRS) prevalence rates for HbA1c, 
blood pressure, proliferative retinopathy and 
clinically significant macular oedema. Levels 
above 1 indicate an increased prevalence till 
today; levels below one indicates decreased 
prevalence till today.
Fig 2
The association between an internationally approved retinopathy 
scale and the number of frequently occurring retinal lesions 
(microaneurysms, intraretinal haemorrhages, hard exudates and 
soft exudates).
Fig 3
The association between an internationally 
approved retinopathy scale and the 
prevalence of clinically significant macular 
oedema.
Conclusion
1. The prevalence of proliferative retinopathy seems lower than 
in previous studies.
2. The prevalence of clinically significant macular oedema 
seems increased compared to previous studies.
3. There is a non-linear association between the retinal grading 
and the number of retinal lesions.
4. There is a non-linear association between the retinal grading 
and the prevalence of clinically significant macular oedema.
